9,300 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Purchased by Polymer Capital Management US LLC

Polymer Capital Management US LLC bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 9,300 shares of the company's stock, valued at approximately $361,000.

Other hedge funds also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $26,000. SRS Capital Advisors Inc. boosted its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares in the last quarter. UMB Bank n.a. grew its position in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after buying an additional 335 shares during the period. Lindbrook Capital LLC increased its holdings in Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after buying an additional 431 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works in the third quarter worth about $39,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on BBWI. Argus restated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Robert W. Baird raised their price objective on Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. Barclays reduced their target price on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research note on Monday, March 3rd. JPMorgan Chase & Co. set a $47.00 price target on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, Cowen reissued a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $44.06.

Bath & Body Works Stock Down 3.9 %

Shares of Bath & Body Works stock traded down $1.08 on Friday, hitting $26.54. 7,878,161 shares of the company were exchanged, compared to its average volume of 4,677,503. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99. The stock has a market capitalization of $5.69 billion, a price-to-earnings ratio of 6.47, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. The company has a 50-day moving average price of $32.99 and a 200 day moving average price of $34.00.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 3.01%. Bath & Body Works's payout ratio is 21.98%.

Bath & Body Works announced that its board has approved a stock buyback plan on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.